Product image of Noradrenaline Sans Sulfites Viatris (Noradrenaline Tartrate) supplied by GNH India

Noradrenaline Sans Sulfites Viatris

Active Ingredient:
Noradrenaline Tartrate
Origin:
EU

Noradrenaline Sans Sulfites Viatris (Noradrenaline Tartrate)

Noradrenaline, the active ingredient in Noradrenaline Sans Sulfites Viatris, is an adrenergic agonist presented as an injection solution for intravenous use. It treats acute hypotension, septic shock, cardiac arrest and post‑cardiac surgery low output syndrome in hospital settings under close medical supervision and intensive care units.

GNH India supplies Noradrenaline Sans Sulfites Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide with rigorous quality assurance and reliable logistics for critical care medicines.

Manufacturer / TM Owner

Viatris Sante

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Noradrenaline is a vasopressor that acts on the adrenergic system to restore blood pressure in critical care settings.

  • Acute hypotension: raises systemic vascular resistance to increase arterial pressure.
  • Septic shock: improves organ perfusion by vasoconstriction and enhanced cardiac output.
  • Cardiac arrest: provides circulatory support during resuscitation efforts.
  • Post‑cardiac surgery low output syndrome: augments cardiac output and systemic pressure.

How It Works

  • Noradrenaline acts as a direct agonist at α1‑adrenergic receptors causing peripheral vasoconstriction and at β1‑adrenergic receptors increasing myocardial contractility and heart rate. Through activation of intracellular signaling pathways that increase calcium influx in vascular smooth muscle and cardiac myocytes, the drug further enhances contractile force. The combined effect raises systemic vascular resistance and cardiac output, leading to rapid elevation of arterial pressure in patients with circulatory failure.

Side Effects

Noradrenaline may be associated with a range of adverse reactions, varying from frequent to rare but serious.

Common Side Effects

  • Tachycardia: increased heart rate.
  • Headache: transient cranial pain.
  • Nausea: mild gastrointestinal upset.
  • Peripheral ischemia: reduced blood flow to extremities causing discomfort.

Serious or Rare Side Effects

  • Arrhythmias: potentially life‑threatening rhythm disturbances.
  • Myocardial ischemia: reduced oxygen supply to heart muscle.
  • Severe hypertension: abrupt excessive rise in blood pressure.
  • Tissue necrosis at infusion site: local tissue death due to extravasation.

Precautions & Warnings

When using Noradrenaline, careful clinical monitoring and adherence to handling guidelines are essential.

  • Cardiovascular monitoring: continuous blood pressure and heart rate assessment.
  • Dose titration: adjust infusion rate to achieve target MAP while avoiding excessive hypertension.
  • Contraindications: avoid in patients with known hypersensitivity to noradrenaline or sulfite‑containing products.
  • Drug interactions: monitor closely when combined with beta‑blockers or MAO inhibitors.
  • Extravasation risk: stop infusion immediately if signs of infiltration appear and manage according to protocol.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Noradrenaline can interact with several medicines, influencing its pressor effect or safety profile.

Major Interactions (Avoid)

  • MAO inhibitors: may cause hypertensive crisis.
  • Tricyclic antidepressants: potentiate vasoconstriction and raise blood pressure.
  • Ergot alkaloids: increase risk of severe vasospasm.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may blunt tachycardia response.
  • Calcium channel blockers: additive effects on blood pressure.
  • Diuretics: may alter intravascular volume and affect response.
  • Vasodilators: may reduce efficacy of noradrenaline.

Frequently Asked Questions

Noradrenaline Sans Sulfites Viatris is used in hospital and intensive‑care settings to treat acute hypotension, septic shock, cardiac arrest, and post‑cardiac surgery low output syndrome by rapidly raising blood pressure and supporting cardiac output.

Noradrenaline acts as a direct agonist at α1‑adrenergic receptors, causing peripheral vasoconstriction, and at β1‑adrenergic receptors, increasing heart contractility and rate. The combined actions raise systemic vascular resistance and cardiac output, restoring arterial pressure in circulatory failure.

The dose of Noradrenaline Sans Sulfites Viatris is determined individually by the prescribing clinician based on the patient’s hemodynamic status, target blood pressure, and response to therapy. No fixed regimen is provided here.

Safety data for Noradrenaline in pregnancy or lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by the treating physician.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Noradrenaline is the first‑line vasopressor for most forms of acute hypotension because of its strong α1‑mediated vasoconstriction and modest β1 activity. Compared with agents such as dopamine or phenylephrine, it offers more predictable blood pressure control with fewer tachyarrhythmic effects.

The product must be stored refrigerated at 2‑8 °C, protected from light, and must never be frozen or shaken. It should be kept in its original packaging to maintain sterility and potency until use.

Noradrenaline is supplied as a sterile injection solution for intravenous infusion. It is typically administered via a calibrated infusion pump, with the rate adjusted continuously to achieve the desired mean arterial pressure while monitoring cardiovascular parameters.

Serious risks include severe hypertension, myocardial ischemia, life‑threatening arrhythmias, and tissue necrosis if the drug extravasates from the vein. Continuous hemodynamic monitoring and prompt management of infusion site complications are essential to mitigate these risks.

Patients with known hypersensitivity to noradrenaline or sulfite‑containing products, or those in whom vasoconstriction is contraindicated (e.g., severe peripheral vascular disease), should not receive this medication. Clinical judgment is required for each individual case.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Noradrenaline Tartrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT